Ali McBride, PharmD, MS, BCOP, discussed during the recent National Oncology Conference his goals for ACCC while serving as president, which include focusing on education, innovation, and compensation.<br />
Ali McBride, PharmD, MS, BCOP, president, Association of Community Cancer Centers (ACCC), and clinical coordinator, Hematology/Oncology, the University of Arizona Cancer Center, discussed during the recent National Oncology Conference his goals for ACCC while serving as president, which include focusing on education, innovation, and compensation.
Compensation is often not measured across the continuum of care, which makes it an important focus in the ACCC. In cancer care today, alternative payment models and oncology care models are popular themes, and the common denominator is the understanding of which people play a role in patient care within cancer centers. The care team can include physicians, nutritionists, pharmacists, nurse navigators, triage nurses, and advanced practitioners. Together, these clinicians create an environment of collaborative care in which there are multiple point persons.
Having a clear picture of which people are involved in care is important for both the patient and care team because these are the individuals monitoring the patient’s treatment and ultimately driving the future of oncology care models.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More